Quick Takeaways
- David J. Mauro has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $1,392,024.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of David J. Mauro
- Location
- Washington Cross, PA
- Summary
- The estimated net worth of David J. Mauro is at least $1,392,024 dollars as of 19 Nov 2024. David J. Mauro is the Chief Medical Officer of RECURSION PHARMACEUTICALS, INC. and owns shares of RECURSION PHARMACEUTICALS, INC. (RXRX) stock worth about $1.39M.
- Signature
- /s/Jonathan Golightly, attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David J. Mauro and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: RECURSION PHARMACEUTICALS, INC. ($1,392,024).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David J. Mauro
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Chief Medical Officer | $1,392,024 | 15 Nov 2024 | ||
| CDAKQ | Codiak BioSciences, Inc. | Chief Medical Officer | 24 Jan 2023 | |||
| PRLD | Prelude Therapeutics Inc | Chief Medical Officer | 05 Oct 2021 |
Insider Transactions Reported by David J. Mauro:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.